
Primiliv Pharmaceuticals Private Limited
About Primiliv Pharmaceuticals Private Limited
Data last updated:
Primiliv Pharmaceuticals Private Limited was a private limited company based in Nagpur, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the health and beauty retail and distribution segment of the consumer goods sector. It was incorporated on 29 August 2017.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC299124.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Mayur Sanjay Nawale and Kunda Sanjay Nawale.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Plot No 29 Shivsakti Nagar, Nagpur, Maharashtra, India – 440024.
Company details
Contact details
Primiliv Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 29 Shivsakti Nagar, Nagpur, Maharashtra, India – 440024
- IndustryConsumer Goods, Health & Beauty Retail & Distribution
To see the full contact details of Primiliv Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Primiliv Pharmaceuticals Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Primiliv Pharmaceuticals Private Limited, buy the company report.
Board of directors of Primiliv Pharmaceuticals Private Limited
Primiliv Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayur Sanjay Nawale Also directs: Shritik Pharma Private Limited | Director | 10 May 2018 | 8 Years 6 Months | As last reported |
| Kunda Sanjay Nawale | Director | 29 Aug 2017 | 9 Years 2 Months | As last reported |
Legal cases
No court or tribunal cases involving Primiliv Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Primiliv Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Primiliv Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Primiliv Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Giteshwari Jayshankar Lede ceased to be Director on 10 May 2018.
Frequently asked questions
Primiliv Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Primiliv Pharmaceuticals was a private limited company based in Nagpur, Maharashtra, India. The company worked in health and beauty retail and distribution, within the consumer goods industry. It was incorporated on 29 August 2017 and is registered under CIN U74999MH2017PTC299124. The company has been struck off by the Registrar of Companies and is no longer operational.
Primiliv Pharmaceuticals had 2 directors:
- Mayur Sanjay Nawale - Director
- Kunda Sanjay Nawale - Director
The CIN (Corporate Identification Number) of Primiliv Pharmaceuticals is U74999MH2017PTC299124. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Primiliv Pharmaceuticals is at Plot No 29 Shivsakti Nagar, Nagpur, Maharashtra, India – 440024.
Primiliv Pharmaceuticals was incorporated on 29 August 2017. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Primiliv Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2018 are in the company report.
Primiliv Pharmaceuticals operated in the consumer goods industry, in the health and beauty retail and distribution segment. It worked in this industry before it was struck off.
Giteshwari Jayshankar Lede ceased to be Director on 10 May 2018. Mayur Sanjay Nawale was appointed as Director on 10 May 2018. Kunda Sanjay Nawale was appointed as Director on 29 Aug 2017.
The compliance status of Primiliv Pharmaceuticals is compliant as of 21 September 2026.

